Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pettinelli

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The New England Journal of Medicine|August 27, 1992
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials GroupJ O Kahn, S W Lagakos, D D Richman, et al.
Archives of Internal Medicine|May 8, 1995
Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials GroupR Dolin, D A Amato, M A Fischl, et al.
The New England Journal of Medicine|October 10, 1996
Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDSL D Saravolatz, D L Winslow, G Collins, et al.
The New England Journal of Medicine|April 15, 1990
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious DiseasesP A Volberding, S W Lagakos, M A Koch, et al.
The Journal of Infectious Diseases|October 7, 2000
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359R M Gulick, X J Hu, S A Fiscus, et al.
AIDS (London, England)|July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 InvestigatorsD R Kuritzkes, I Marschner, V A Johnson, et al.
Antiviral Therapy|April 1, 1996
Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068D Mildvan, Y Bassiakos, M L Zucker, et al.
Statistics in Medicine|November 20, 1998
Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshopJ M Albert, J P Ioannidis, P Reichelderfer, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The New England Journal of Medicine|August 27, 1992
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials GroupJ O Kahn, S W Lagakos, D D Richman, et al.
Archives of Internal Medicine|May 8, 1995
Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials GroupR Dolin, D A Amato, M A Fischl, et al.
The New England Journal of Medicine|October 10, 1996
Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDSL D Saravolatz, D L Winslow, G Collins, et al.
The New England Journal of Medicine|April 15, 1990
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious DiseasesP A Volberding, S W Lagakos, M A Koch, et al.
The Journal of Infectious Diseases|October 7, 2000
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359R M Gulick, X J Hu, S A Fiscus, et al.
AIDS (London, England)|July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 InvestigatorsD R Kuritzkes, I Marschner, V A Johnson, et al.
Antiviral Therapy|April 1, 1996
Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068D Mildvan, Y Bassiakos, M L Zucker, et al.
Statistics in Medicine|November 20, 1998
Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshopJ M Albert, J P Ioannidis, P Reichelderfer, et al.
Pageof 2